working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Q3 23: Stable volume growth underpinned by a recovery in key segments

Companies: Novozymes (NZYM-B:CPH)Novonesis A/S Class B (NSIS.B:CSE)

Household Care recovering but no respite for Bioenergy

Companies: Novonesis A/S Class B

Q2 23: Broad-based weakness leads to a guidance downgrade

Companies: Novozymes (NZYM-B:CPH)Novonesis A/S Class B (NSIS.B:CSE)

Crude reality check triggers FY 17-20 downgrade

Companies: Novonesis A/S Class B

BioEnergy surprise drives Q1 23 momentum

Companies: Novozymes (NZYM-B:CPH)Novonesis A/S Class B (NSIS.B:CSE)

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top